NDT Pharmaceuticals' Good Salt(TM) Life Subsidiary Unveils Scalable Antimicrobial Platform to Drive Health, Safety, and Sustainability Across Global Markets
NDT Pharmaceuticals (OTCID:NDTP) announced its subsidiary Good Salt™ Life's strategic expansion into the $148 billion global biosafety market with an innovative antimicrobial platform. The company's technology transforms salt and water into hypochlorous acid (HOCl) solutions through proprietary electrolysis, targeting home care, pet wellness, skincare, and professional biosafety sectors.
Good Salt Life has secured partnerships with major industry leaders including Virgin, Royal Caribbean, Carnival Corp, Cleveland Clinic, New York Yankees, and major retailers like Amazon, Walmart, and Chewy. The company's EPA-registered solutions are being implemented across various sectors including animal health, cruise industry, healthcare, government facilities, and sports venues.
The company is also investing in next-generation technologies including robotics, AI automation, and indoor air quality sensors to build a comprehensive safety solutions ecosystem.
NDT Pharmaceuticals (OTCID:NDTP) ha annunciato l'espansione strategica della sua filiale Good Salt™ Life nel mercato globale della biosicurezza, valutato 148 miliardi di dollari, con una piattaforma antimicrobica innovativa. La tecnologia dell'azienda trasforma sale e acqua in soluzioni di acido ipocloroso (HOCl) tramite elettrolisi proprietaria, mirando ai settori della cura della casa, benessere degli animali, cura della pelle e biosicurezza professionale.
Good Salt Life ha stretto partnership con importanti leader del settore tra cui Virgin, Royal Caribbean, Carnival Corp, Cleveland Clinic, New York Yankees, e grandi rivenditori come Amazon, Walmart e Chewy. Le soluzioni registrate EPA dall'azienda sono implementate in diversi settori tra cui salute animale, settore delle crociere, assistenza sanitaria, strutture governative e impianti sportivi.
L'azienda sta inoltre investendo in tecnologie di prossima generazione, tra cui robotica, automazione IA e sensori di qualità dell'aria indoor, per creare un ecosistema completo di soluzioni di sicurezza.
NDT Pharmaceuticals (OTCID:NDTP) anunció la expansión estratégica de su subsidiaria Good Salt™ Life hacia el mercado global de bioseguridad, valorado en 148 mil millones de dólares, con una plataforma antimicrobiana innovadora. La tecnología de la empresa transforma la sal y el agua en soluciones de ácido hipocloroso (HOCl) mediante electrólisis propietaria, enfocándose en cuidado del hogar, bienestar de mascotas, cuidado de la piel y bioseguridad profesional.
Good Salt Life ha asegurado asociaciones con líderes de la industria como Virgin, Royal Caribbean, Carnival Corp, Cleveland Clinic, New York Yankees, y minoristas importantes como Amazon, Walmart y Chewy. Las soluciones registradas por la EPA de la empresa se están implementando en diversos sectores, incluidos salud animal, industria de cruceros, atención médica, instalaciones gubernamentales y recintos deportivos.
La empresa también está invirtiendo en tecnologías de próxima generación, incluida robótica, automatización de IA y sensores de calidad del aire interior para crear un ecosistema completo de soluciones de seguridad.
NDT Pharmaceuticals (OTCID:NDTP)는 자회사 Good Salt™ Life의 전략적 확장을 1480억 달러 규모의 글로벌 생물안전 시장으로 발표했습니다. 혁신적인 항미이크로비얼 플랫폼과 함께, 회사의 기술은 소금과 물을 특허 받은 전기분해를 통해 차아 진화 HOCl 솔루션으로 전환하여 가정 관리, 반려동물 건강, 피부 관리 및 전문적 생물안전 부문을 겨냥합니다.
Good Salt Life는 Virgin, Royal Caribbean, Carnival Corp, Cleveland Clinic, New York Yankees 등 주요 업계 리더 및 Amazon, Walmart, Chewy와 같은 주요 소매업체와의 파트너십을 확보했습니다. EPA 등록 솔루션은 동물 건강, 크루즈 산업, 의료, 정부 시설, 스포츠 경기장 등 다양한 부문에 적용 중입니다.
회사는 또한 로봇공학, AI 자동화, 실내 공기질 센서 등 차세대 기술에 투자하여 포괄적인 안전 솔루션 생태계를 구축하고 있습니다.
NDT Pharmaceuticals (OTCID:NDTP) a annoncé l'expansion stratégique de sa filiale Good Salt™ Life sur le marché mondial de biosécurité, évalué à 1480 milliards de dollars, avec une plateforme antimicrobienne innovante. La technologie de l'entreprise transforme le sel et l'eau en solutions d'acide hypochloreux (HOCl) via une électrolyse propriétaire, visant les secteurs de l'entretien domestique, du bien-être des animaux, des soins de la peau et de la biosécurité professionnelle.
Good Salt Life a conclu des partenariats avec des leaders majeurs de l'industrie tels que Virgin, Royal Caribbean, Carnival Corp, Cleveland Clinic, New York Yankees, et des détaillants importants comme Amazon, Walmart et Chewy. Les solutions enregistrées par l'EPA de l'entreprise sont mises en œuvre dans divers secteurs, notamment la santé animale, l'industrie des croisières, les soins de santé, les facilities gouvernementales et les sites sportifs.
L'entreprise investit également dans des technologies de prochaine génération, notamment la robotique, l'automatisation par IA et les capteurs de qualité de l'air intérieur pour construire un écosystème complet de solutions de sécurité.
NDT Pharmaceuticals (OTCID:NDTP) kündigte die strategische Expansion seiner Tochtergesellschaft Good Salt™ Life in den globalen Biosicherheitsmarkt im Wert von 148 Milliarden US-Dollar mit einer innovativen antimikrobiellen Plattform an. Die Technologie des Unternehmens wandelt Salz und Wasser durch proprietäre Elektrolyse in Lösungen von Hypochlorous Acid HOCl um, wobei Haushaltspflege, Haustiergesundheit, Hautpflege und professionelle Biosicherheitkanäle anvisiert werden.
Good Salt Life hat Partnerschaften mit führenden INDUSTRIE-Partnern einschließlich Virgin, Royal Caribbean, Carnival Corp, Cleveland Clinic, New York Yankees und großen Einzelhändlern wie Amazon, Walmart und Chewy gesichert. Die EPA-registrierten Lösungen des Unternehmens werden in Bereichen wie Tiergesundheit, Kreuzfahrtindustrie, Gesundheitswesen, Regierungsgebäuden und Sportstätten eingesetzt.
Das Unternehmen investiert auch in Zukunftstechnologien wie Robotik, KI-Automatisierung und Sensoren zur Innenraumluftqualität, um ein umfassendes Sicherheitslösungs-Ökosystem aufzubauen.
NDT Pharmaceuticals (OTCID:NDTP) أعلن عن التوسع الاستراتيجي لذراعها Good Salt™ Life في السوق العالمية للسلامة الحيوية التي تبلغ قيمتها 148 مليار دولار أمريكي من خلال منصة مضادة للميكروبات مبتكرة. تقنيات الشركة تحول الملح والماء إلى محاليل حمضHypochlorous HOCl من خلال التحليل الكهربائي المملوك، مستهدفةً مجالات الرعاية المنزلية، ورفاهية الحيوانات الأليفة، والعناية بالبشرة، والسلامة الحيوية المهنية.
قامت Good Salt Life بتأمين شراكات مع قادة صناعيين كبار بما في ذلك Virgin وRoyal Caribbean وCarnival Corp وCleveland Clinic وNew York Yankees، وكذلك بائعي التجزئة الرئيسيين مثل Amazon وWalmart وChewy. الحلول المسجلة لدى EPA من الشركة تُطبّق عبر قطاعات متعددة بما فيها صحة الحيوان، صناعة الرحلات البحرية، الرعاية الصحية، المرافق الحكومية، وميادين الرياضة.
تستثمر الشركة أيضاً في تقنيات الجيل القادم بما في ذلك الروبوتات، وأتمتة الذكاء الاصطناعي، وأجهزة استشعار جودة الهواء الداخلي لبناء منظومة كاملة من حلول السلامة.
NDT Pharmaceuticals (OTCID:NDTP) 宣布其子公司 Good Salt™ Life 在全球生物安全市场的战略扩张，该市场规模达 1480 亿美元，推出创新的抗菌平台。公司的技术通过专有电解将盐和水转化为次氯酸（HOCl）溶液，面向家居护理、宠物健康、护肤和专业生物安全等领域。
Good Salt Life 已与 Virgin、Royal Caribbean、Carnival Corp、Cleveland Clinic、New York Yankees，以及亚马逊、Walmart、Chewy 等大型行业领袖和零售商建立合作伙伴关系。公司注册于 EPA 的解决方案正在动物健康、邮轮行业、医疗保健、政府设施和体育场馆等多个领域实施。
公司也在投资下一代技术，包括机器人、人工智能自动化和室内空气质量传感器，以建立全面的安全解决方案生态系统。
- Established partnerships with major industry leaders across multiple sectors
- Operating in a large $148 billion global biosafety market opportunity
- EPA-registered and third-party tested products with proven efficacy
- Strong distribution network through major retailers and e-commerce platforms
- Development of next-generation technologies including robotics and AI automation
- Operating in a highly competitive market with established players
- Significant investment required for next-generation technology development
ATHENS, GEORGIA / ACCESS Newswire / September 23, 2025 / Good Salt™ Life, Inc., a wholly owned subsidiary of NDT Pharmaceuticals Inc. (OTCID:NDTP) ("NDTP" or the "Company"), today shared insight into its strategic initiative designed to build value through investments in sustainable, science-driven health and wellness brands that protect people, pets, and the planet. Good Salt Life targets the
At the heart of Good Salt Life's innovation is hypochlorous acid (HOCl), a naturally occurring substance produced by the human body to combat infection. Through proprietary electrolysis, Good Salt Life transforms salt and water into powerful, eco-friendly solutions for home care, pet wellness, skincare, and professional biosafety. The Company's products are non-toxic, family-safe, and environmentally conscious, meeting the highest performance standards backed by EPA registration and rigorous third-party testing.
Trusted by Industry Leaders
Good Salt Life's breakthrough technologies have earned the trust of leading organizations across multiple sectors, including:
Animal Health: Strengthening welfare and biosecurity outcomes in critical environments to reduce mortality and ensure human health.
Cruise Industry: Partnering with industry giants such as Virgin, Royal Caribbean, Carnival Corp, and Norwegian Cruise Line to establish new benchmarks for passenger health and safety at sea.
Education & Healthcare: Providing solutions to renowned institutions like the Baptist Hospital System and Cleveland Clinic, ensuring the safety of vulnerable populations in hospitals and schools.
Government & Nonprofits: Offering proven solutions for maintaining hygiene in the Tennessee State Prison System, NY State Prison, New York City Fire Department, and Ronald McDonald House.
Sports: Collaborating with the New York Yankees, Boston Red Sox, Tampa Bay Rays, and NCAA programs including Ole Miss, Alabama, Clemson, LSU, and WKU Football to enhance safety and health standards.
Retail and E-Commerce: Expanding reach through partnerships with major distributors such as Amazon, Chewy, Walmart, Staples, Ecolox Tech, Imperial Dade, Veritiv, and System Chemical, making innovative products accessible to consumers.
Driving Scalable Impact
From households to large institutions, Good Salt Life's solutions are reshaping the meaning of cleanliness and protection. Whether reducing pathogens in animal shelters, safeguarding healthcare workers on the frontlines, or ensuring cruise passengers travel with peace of mind, Good Salt Life is scaling across markets where safety and sustainability are essential.
Investing in the Future
Good Salt Life is also focused on next-generation technologies that extend beyond chemistry. With advancements in robotics, AI-driven automation, and pioneering indoor air quality sensors, Good Salt Life is building a holistic ecosystem of safety solutions. These innovations will reduce labor costs, improve efficiency, and provide proactive protection against emerging health risks.
Commitment to Responsibility
"Good Salt Life stands at the intersection of innovation and responsibility," said Zach O'Shea, President and CEO of NDT Pharmaceuticals. "We are not just creating products; we are building a platform for healthier living, animal welfare, and environmental stewardship. As we grow alongside world-class partners and distributors, our vision remains clear: to lead the global shift toward safer, cleaner, and more sustainable living for future generations."
About NDT Pharmaceuticals, Inc. (OTC:NDTP)
NDT Pharmaceuticals, Inc. (OTC:NDTP) is a publicly traded company focused on advancing innovative consumer health and wellness solutions. With its recent acquisition of Good Salt Life Inc., NDTP has expanded its strategic direction into sustainable, science-driven products that promote healthier living. The Company is committed to building value through investments in brands that protect people, pets, and the planet while aligning with growing consumer demand for eco-friendly and health-conscious alternatives.
About Good Salt Life, Inc.
Good Salt Life is dedicated to promoting vitality through eco-friendly, nature-derived products that support healthier living environments. With a focus on innovation and sustainability, the company offers safe and effective solutions for home, pet, personal care, and animal health. Through strategic partnerships, including collaborations in the B2B animal health sector, Good Salt Life continues to drive advancements that benefit both people and animals. For more information, visit www.goodsaltlife.com.
Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company's current expectations and speak only as of the date of this release. Actual results may differ materially from the Company's current expectations. Except as required by law, the Company does not undertake any responsibility to revise or update any forward-looking statements.
Contact:
SOURCE: NDT Pharmaceuticals Inc.
View the original press release on ACCESS Newswire
FAQ
What is Good Salt Life's main product technology and how does it work?
Which major companies have partnered with NDTP's Good Salt Life?
What is the market size for NDT Pharmaceuticals' biosafety solutions?
How is NDTP planning to expand its technology platform?
What industries does Good Salt Life serve?
